Published in Br Med J (Clin Res Ed) on June 25, 1983
Deployment of resources in treatment of end stage renal failure in England and Wales. Br Med J (Clin Res Ed) (1984) 2.41
Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis (2012) 1.81
Simulation model for planning renal services in a district health authority. BMJ (1992) 1.73
Renal replacement treatment in patients with spina bifida or spinal cord injury. BMJ (1989) 1.38
Why don't the British treat more patients with kidney failure? Br Med J (Clin Res Ed) (1983) 1.36
Late referral for maintenance dialysis. Br Med J (Clin Res Ed) (1984) 1.25
Impact of continuous ambulatory peritoneal dialysis on treatment of renal failure in patients aged over 60. Br Med J (Clin Res Ed) (1984) 1.22
Using simulation to plan Health Service resources: discussion paper. J R Soc Med (1986) 0.99
Treatment of end stage renal disease. Br Med J (Clin Res Ed) (1984) 0.83
Renal replacement therapy in patients aged over 60 years. Postgrad Med J (1987) 0.79
The renal unit in Inverness: the shape of things to come? Br Med J (Clin Res Ed) (1984) 0.75
Maximum utilization of the life table method in analyzing survival. J Chronic Dis (1958) 22.07
Combined report on regular dialysis and transplantation in Europe. X, 1979. Proc Eur Dial Transplant Assoc (1980) 3.12
Over 50 and uremic equals death. The failure of the British National Health Service to provide adequate dialysis facilities. Nephron (1982) 2.12
Combined report on regular dialysis and transplantation in Europe, VIII, 1977. Proc Eur Dial Transplant Assoc (1978) 1.85
Combined report on regular dialysis and transplantation in Europe, XI, 1980. Proc Eur Dial Transplant Assoc (1981) 1.68
High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial. Br Med J (Clin Res Ed) (1983) 1.34
Renal transplantation in patients over 50 years of age. Transplant Proc (1981) 1.12
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. QJM (2002) 3.09
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest (1974) 2.81
Schönlein-Henoch nephritis. Q J Med (1972) 2.64
Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol (1972) 2.60
10 years' experience with regular haemodialysis and renal transplantation. Arch Dis Child (1980) 2.56
The complement abnormalities of lipodystrophy. N Engl J Med (1976) 2.40
The simple assessment of selectivity in heavy proteinuria. Lancet (1966) 2.36
Why the persistently high mortality in acute renal failure. Lancet (1972) 2.32
Prognosis of Henoch-Schönlein nephritis in children. Br Med J (1977) 2.32
Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J (1966) 2.31
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07
Serum immune complexes and disease activity in lupus nephritis. Lancet (1977) 2.07
Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet (1973) 2.00
Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J (1969) 1.99
Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis. Lancet (1973) 1.93
Changes in leucocyte migration after renal transplantation. Br Med J (1969) 1.91
Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med (1975) 1.81
Genetics of classic Alport's syndrome. Lancet (1988) 1.73
Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med (1983) 1.70
Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol (1974) 1.67
Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis. Lancet (1974) 1.62
Children referred for acute dialysis. Arch Dis Child (1971) 1.58
Is repeated flushing of Hickman catheters necessary? Br Med J (Clin Res Ed) (1985) 1.57
The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol (1984) 1.55
Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides. Immunology (1986) 1.54
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
Plasma C3 and C4 concentrations in management of glomerulonephritis. Br Med J (1973) 1.53
Long-term outcome for children with minimal-change nephrotic syndrome. Lancet (1985) 1.52
Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol (1982) 1.49
Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. Clin Sci (Lond) (1990) 1.49
Broadcast television for Doctors-a first evaluation. Br Med J (1966) 1.48
Renal grafts from non-heart beating donors. BMJ (1994) 1.47
Parathyroidectomy in the treatment of secondary renal hyperparathyroidism. Kidney Int (1973) 1.46
Hydrothorax after central venous catheterization. Br Med J (1973) 1.46
Monoclonal antibodies to the Sjögren's syndrome associated antigen SS-B (La). J Immunol Methods (1985) 1.46
Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block. Paediatr Anaesth (2004) 1.44
Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol (1990) 1.44
The identification of 2,8-dihydroxyadenine, a new component of urinary stones. Biochem J (1976) 1.43
Treatment of resistant CAPD peritonitis by temporary discontinuation of peritoneal dialysis. Clin Nephrol (1989) 1.42
Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J (1970) 1.41
A review of the literature on cocaine abuse in pregnancy. Nurs Res (1991) 1.40
Histology, protein clearances, and response to treatment in the nephrotic syndrome. Br Med J (1968) 1.39
Cimetidine: prophylaxis against upper gastrointestinal haemorrhage after renal transplantation. Br Med J (1978) 1.39
Percutaneous transluminal renal angioplasty in patients with renal failure. Q J Med (1993) 1.39
Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies. Kidney Int (1987) 1.37
Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. Clin Exp Immunol (1989) 1.36
Treatment of end-stage renal failure due to diabetes in the United Kingdom, 1975-84. Lancet (1986) 1.34
High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial. Br Med J (Clin Res Ed) (1983) 1.34
Transformation of lymphocytes from patients awaiting cadaver renal transplants. Lancet (1976) 1.32
Hypocomplementaemic membranoproliferative glomerulonephritis and nephrotic syndrome associated with partial lipodystrophy of the face and trunk. Proc R Soc Med (1972) 1.31
IgA and glomerular disease. Clin Nephrol (1976) 1.31
Expression of VCAM-1 in the normal and diseased kidney. Nephrol Dial Transplant (1991) 1.30
Immune response to HBsAg and the spectrum of liver lesions in HBsAg-positive patients with chronic renal disease. Br Med J (1976) 1.30
Seasonal nephrotic syndrome. Description and immunological findings. Clin Allergy (1975) 1.29
Analysis of 100 children with severe and persistent hypertension. Arch Dis Child (1976) 1.28
Immune responses in uremia. Clin Nephrol (1974) 1.28
Clinical evaluation of a rosette inhibition test in renal allotransplantation. Br Med J (1971) 1.27
Nephrotic syndrome due to primary renal disease in adults: I. Survey of incidence in South-east England. Br Med J (1969) 1.27
The urological complications of 1000 renal transplants. Br J Urol (1981) 1.26
Relapsing polychondritis with crescentic glomerulonephritis. Br Med J (1978) 1.25
Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet (1989) 1.23
Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int (1990) 1.22
Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol (1976) 1.22